Our study illustrates that olanzapine induces weight gain, fasting insulin elevation, glucose intolerance, and increase of TCF7L2 protein expression in liver, skeletal muscle, and adipose tissues of mice. This evidence concerns the gene TCF7L2 and Glucose intolerance.